MGP
protein-codingmatrix Gla protein, the group of Gla domain containing
Gene summary
This gene encodes a member of the osteocalcin/matrix Gla family of proteins. The encoded vitamin K-dependent protein is secreted by chondrocytes and vascular smooth muscle cells, and functions as a physiological inhibitor of ectopic tissue calcification. Carboxylation status of the encoded protein is associated with calcification of the vasculature in human patients with cardiovascular disease and calcification of the synovial membranes in osteoarthritis patients. Mutations in this gene cause Keutel syndrome in human patients, which is characterized by abnormal cartilage calcification, peripheral pulmonary stenosis and facial hypoplasia. [provided by RefSeq, Sep 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0018230
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009495
Submitter: ClinGen
The *MGP* gene (OMIM: 154870) is located on chromosome 12 at 12p12.3 and encodes Matrix Gla protein, a vitamin-K dependent protein that is secreted by chondrocytes and cardiovascular cells and inhibits ectopic tissue calcification. Variants in *MGP* were first reported in relation to autosomal recessive Keutel syndrome in 1999 (Munroe et al., PMID: 9916809). Keutel syndrome is a rare disorder characterized by abnormal cartilage calcification, brachytelephalangy, dysmorphic facial features including midface hypoplasia, and peripheral pulmonary artery stenosis. Other reported features include mixed hearing loss, congenital heart defects, pulmonary hypoplasia, respiratory distress, mild short stature, and mild intellectual disability. Evidence supporting this GDR includes case-level data, segregation data and experimental evidence. 8 unique variants including nonsense and splice variants from 7 publications have been included in this curation. All reported variants are homozygous in the affected individuals and all families were consanguineous. Variants in this gene segregate with disease in at least one family. The suggested mechanism of pathogenicity is loss of function. The gene disease relationship is also supported by a knockout mouse model and phenotype rescue (Luo et al., 1997, PMID: 9052783, Marulanda et al., 2017, PMID: 28487368). In summary, there is definitive evidence supporting the relationship between *MGP* and autosomal recessive Keutel syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date May 16th, 2025 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0009495
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009495
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009495
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009495
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009495
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic
Intervention: Cardiovascular
Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MGP variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000900.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 14 | 15 | |||
| missense | 2 | 33 | 3 | 1 | 39 | |
| nonsense | 1 | 2 | 3 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | 6 | ||
| Total | 3 | 4 | 40 | 17 | 1 | 65 |
Highest pathogenic variant AF is 0.000027304164
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000891.2 | 4 | MANE Select | |
| Ensembl | ENSP00000445907.1 | 4 | MANE Select | |
| RefSeq | NP_001177768.1 | 5 | Standard | |
| Ensembl | ENSP00000228938.5 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Warfarin Pathway, Pharmacodynamics
- NOTCH1 regulation of human endothelial cell calcification
- Endochondral Ossification
- Validated transcriptional targets of AP1 family members Fra1 and Fra2
Biological Process
- cartilage condensation
- ossification
- cell differentiation
- regulation of bone mineralization
Molecular Function
- extracellular matrix structural constituent
- calcium ion binding
- protein binding
- structural constituent of bone
Cellular Component
- extracellular matrix
- collagen-containing extracellular matrix
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000228938
- Coding exons
- 5
- Length
- 4746
- Individuals with no LoFs
- 125705
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125709
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.116 | 69 | 71.8 | 0.962 | 0.00000442 | 826 |
| Missense (PolyPhen) | 30 | 28.762 | 1.043 | 325 | ||
| Synonymous | -0.201 | 27 | 25.7 | 1.05 | 0.00000167 | 227 |
| Loss of Function | 0.209 | 7 | 7.62 | 0.918 | 4.09e-7 | 88 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation.;
- Disease
- DISEASE: Keutel syndrome (KTLS) [MIM:245150]: An autosomal recessive disorder characterized by abnormal cartilage calcification, peripheral pulmonary stenosis neural hearing loss and midfacial hypoplasia. {ECO:0000269|PubMed:9916809}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.545
- RVIS EVS
- 0.77
- RVIS percentile EVS
- 86.95
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |